cardia

(redirected from Gastro-esophageal junction)
Also found in: Thesaurus, Medical, Encyclopedia.

car·di·a

 (kär′dē-ə)
n. pl. car·di·ae (-dē-ē′) or car·di·as
1. The opening of the esophagus into the stomach.
2. The upper portion of the stomach that adjoins this opening.

[Greek kardiā, heart, cardiac orifice of the stomach; see kerd- in Indo-European roots.]

cardia

(ˈkɑːdɪə)
n
a lower oesophageal sphincter

car•di•a

(ˈkɑr di ə)

n., pl. -di•ae (-diˌi)
-di•as.
an opening that connects the esophagus and the upper part of the stomach.
[1775–85; < New Latin < Greek kardía, literally, heart]

-cardia

a combining form occurring in words that denote an anomalous or undesirable action or position of the heart, as specified by the initial element: tachycardia.
[perhaps orig. representing Greek kardía heart, though coincidence with the abstract n. suffix -ia has influenced sense]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.cardia - the opening into the stomach and that part of the stomach connected to the esophagus
orifice, porta, opening - an aperture or hole that opens into a bodily cavity; "the orifice into the aorta from the lower left chamber of the heart"
Translations

cardia

n. cardia, desembocadura del esófago en el estómago.
References in periodicals archive ?
Abstract #TPS4139, Poster #247a: The BRIGHTER trial: A phase 3 randomized, double-blind, placebo-controlled clinical trial of first-in-class cancer stemness inhibitor BBI608 plus weekly paclitaxel versus placebo plus weekly paclitaxel in adult patients with advanced, previously treated gastric and gastro-esophageal junction (GEJ) adenocarcinoma
One monoclonal Antibody (mAb), Herceptin (trastuzumab) is marketed for use in suitable patients with advanced gastric or gastro-esophageal junction cancer.
PharmaEngine completed a multi-national (Europe and Asia) randomized non-comparative phase II study of PEP02, irinotecan, or docetaxel as a second line treatment in gastric or gastro-esophageal junction adenocarcinoma.